About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/17/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/17/2021.

The Color of Itch; Itch Modification by Color Viewing

Clinicaltrials.gov identifier NCT03928223

Recruitment Status Completed

First Posted April 26, 2019

Last update posted April 26, 2019

Study Description

Brief summary:

Itch is the commonest skin-related symptom. There is increasing evidence that itch can be influenced by visual cues. The impact of colors on itch has not yet been studied. This study investigates Itch modification by color viewing and whether patients can match or counteract their itch with a color.

  • Condition or Disease:Itch
    Pruritus
  • Intervention/Treatment: Other: exploratory survey on Itch modification by color viewing
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Observational
  • Actual Enrollment: 72 participants
  • Observational Model: Cohort
  • Time Perspective: Prospective
  • Official Title: The Color of Itch; Itch Modification by Color Viewing- an Exploratory Survey
  • Actual Study Start Date: March 2017
  • Actual Primary Completion Date: August 2018
  • Actual Study Completion Date: August 2018
Outcome Measures
  • Primary Outcome Measures: 1. Change in itch intensity [ Time Frame: assessed at baseline and again after the patients looked at the "antipruritic" color for 5 minutes ]
    Change in itch intensity (measured on a 0-10 Numerical Rating Scale, NRS); 0 = no itch; 10 = most intensive itch
Eligibility Criteria
  • Ages Eligible for Study: 16 Years and older (Child, Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
  • Sampling Method: Probability Sample
  • Study Population: Dermatology in- and outpatients with itch in the Department of Dermatology of the University Hospital Basel.
Criteria

Inclusion Criteria:

- Dermatology in- and outpatients with itch

Exclusion Criteria:

- color blindness

- lack of time

- lack of German language.

Contacts and Locations
Contacts
Locations

Switzerland
Department of Dermatology, University Hospital Basel
Basel

Sponsors and Collaborators

University Hospital, Basel, Switzerland

Investigators

Principal Investigator: Simon Müller, Dr. med Department of Dermatology, University Hospital Basel

More Information
  • Responsible Party: University Hospital, Basel, Switzerland
  • ClinicalTrials.gov Identifier: NCT03928223 History of Changes
  • Other Study ID Numbers: Req 2017-1; sp19Mueller4
  • First Posted: April 26, 2019 Key Record Dates
  • Last Update Posted: April 26, 2019
  • Last Verified: April 2019
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by University Hospital, Basel, Switzerland: contagious itch Manchester Color Wheel
  • Additional relevant MeSH terms: Pruritus